Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016
- PMID: 30392765
- DOI: 10.1016/j.vaccine.2018.10.047
Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016
Abstract
Objective: The acellular pertussis vaccine was introduced into the routine childhood immunization schedule across Canada in 1997-98 and adolescent booster doses were added between 1999 and 2005. We sought to assess the impact of these changes on infant pertussis hospitalizations and admissions to intensive care units (ICU) in Canada.
Methods: Hospitalizations with a primary diagnosis of pertussis were extracted from the Canadian Discharge Abstract Database (DAD) for cases with hospital discharge dates between 1981 and 2016 using relevant ICD-9 and ICD-10 codes. Only cases with age less than one year at time of admission were included. Disease severity was assessed by admission to ICU. Cases were categorized into two periods: pre-program implementation period (1981-1995) and the post-program implementation period (2006-2016). Incidence rates, risk ratios, and rate differences were calculated for each period and comparisons for the two periods were done using chi-squared and t-tests. Quasi Poisson analysis was used to investigate trends.
Results: When comparing the pre- and post-implementation periods, the average annual hospitalization rates for infants less than 1 year declined from 165.1 (95% CI 161.3, 168.9) to 33.6 (95% CI 31.6, 35.6) pertussis-related admissions per 100,000 population, with a corresponding reduction in the risk ratio of 4.9 (95% CI 4.6, 5.2). The risk of admission into an ICU was 1.58 times higher in the pre- versus post-implementation period while the highest reduction in average annual hospitalizations was 263.3 admissions per 100,000 population in infants 2 months of age. In the post-implementation period, infants less than 1 month of age had the highest average annual hospitalization rate at 126.6 (95% CI 113.1, 140.1) hospitalizations per 100,000 infants.
Conclusion: Infant pertussis hospitalizations have reduced greatly over time. Infants under 2 months of age remain the most at-risk age group for hospitalization and admission to ICU.
Keywords: Epidemiology; Hospitalization; Pertussis; Post-intervention surveillance, Canada; Trends; Vaccination.
Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Impact of maternal dTpa vaccination on the incidence of pertussis in young infants.PLoS One. 2020 Jan 28;15(1):e0228022. doi: 10.1371/journal.pone.0228022. eCollection 2020. PLoS One. 2020. PMID: 31990945 Free PMC article.
-
The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.Pediatr Infect Dis J. 2007 Jan;26(1):31-5. doi: 10.1097/01.inf.0000247055.81541.04. Pediatr Infect Dis J. 2007. PMID: 17195702
-
Pertussis hospitalizations among infants in the United States, 1993 to 2004.Pediatrics. 2008 Mar;121(3):484-92. doi: 10.1542/peds.2007-1393. Pediatrics. 2008. PMID: 18310196
-
Pertussis: still a cause of death, seven decades into vaccination.Curr Opin Pediatr. 2014 Oct;26(5):597-604. doi: 10.1097/MOP.0000000000000139. Curr Opin Pediatr. 2014. PMID: 25136948 Review.
-
Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization.Expert Rev Vaccines. 2016;15(1):69-80. doi: 10.1586/14760584.2016.1105136. Epub 2015 Nov 11. Expert Rev Vaccines. 2016. PMID: 26559122 Review.
Cited by
-
Pertussis epidemiology in Canada, 2005-2019.Can Commun Dis Rep. 2023 Jan 5;49(1):21-28. doi: 10.14745/ccdr.v49i01a05. eCollection 2023 Jan 5. Can Commun Dis Rep. 2023. PMID: 36815868 Free PMC article.
-
Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine.BMC Health Serv Res. 2020 Apr 9;20(1):295. doi: 10.1186/s12913-020-05115-7. BMC Health Serv Res. 2020. PMID: 32272920 Free PMC article.
-
A Call for Caution in Use of Pertussis Vaccine Effectiveness Studies to Estimate Waning Immunity: A Canadian Immunization Research Network Study.Clin Infect Dis. 2021 Jul 1;73(1):83-90. doi: 10.1093/cid/ciaa518. Clin Infect Dis. 2021. PMID: 32384142 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical